Ethyl 3 2 4 Cyanophenyl Amino Methyl 1 Methyl N Pyridin 2 Yl 1h Benzo D Imidazole 5 Carboxamido Propanoate
quinoline thiophene imidazole thiazole

Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate

Taiy Chemical

Specifications

HS Code

527975

Chemical Name Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
Packing & Storage
Packing
Storage
Shipping
Free Quote

For samples, pricing, or more information, please call us at +8615365036030 or mail to info@alchemist-chem.com.

We will respond to you as soon as possible.

Tel: +8615365036030

Email: info@alchemist-chem.com

General Information
Frequently Asked Questions
The product Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate What is the chemical structure
This is a question about the chemical structure of the compound Ethyl 3- (2- (((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate. To clarify its structure, this lengthy nomenclature needs to be analyzed in detail.
From its name, this compound is composed of many parts. "Ethyl" is one part of the ester group, and it can be known that this compound contains an ester group structure. "3- (2- (((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate" describes another part of the ester group structure in detail.
Wherein, "1H-benzo [d] imidazole" is the core structure of benzimidazole, with methyl substitution at the 1st position of this core structure, and a carboxyamide group at the 5th position, and the nitrogen atom of this carboxyamide group is connected to the pyridine-2-group. At the 2nd position of benzimidazole, there is a structure containing an amino methyl group, and the amino group of this amino methyl group is connected to the 4-cyanophenyl group. And this overall structure is then connected to the propionic acid part of ethyl propionate, thus forming the chemical structure of this compound.
The chemical structure of this compound is complex, and it is cleverly connected by multiple structural units such as benzimidazole, pyridine, and cyanophenyl. Each part affects each other, giving the compound unique chemical and physical properties.
Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) what is the main use of propanoate
Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate is an organic compound, its application is more common in the field of pharmaceutical chemistry, especially in the development of innovative drugs play a key role.
This compound has a unique structure and contains key structural units such as benzimidazole and pyridine. In drug research, benzimidazole structures often have various biological activities, such as anti-tumor, anti-viral, and antibacterial. Pyridine groups also have a significant impact on the specificity and affinity of drug binding to targets. The introduction of cyano groups can change the electron cloud distribution of compounds, which in turn affects their physicochemical properties and biological activities.
In the development of anti-tumor drugs, the compound may inhibit tumor growth by precisely acting on specific targets of cancer cells, interfering with cancer cell proliferation, differentiation or apoptosis-related signaling pathways. Its inhibitory effect on some tumor cells has been shown in preliminary experiments, illuminating the development of new anti-tumor drugs. In terms of antiviral drug exploration, it may interact with viral proteins or nucleic acids to hinder the replication, transcription or assembly process of viruses, providing a new strategy for antiviral therapy.
In the field of antibacterial, this compound may destroy bacterial cell wall synthesis, interfere with bacterial protein synthesis or affect bacterial metabolic pathways, and exert antibacterial effect. Due to its unique structure and potential biological activity, Ethyl 3- (2- ((4-cyanophenyl) amino methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate has become a promising lead compound in the eyes of pharmaceutical chemists. It is expected that through structure optimization and activity screening, innovative drugs with high efficiency and low toxicity will be developed, which will contribute to human health.
Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate
Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate is an organic compound, and its preparation process involves several delicate steps.
The first step is to prepare 4-cyanoaniline derivatives. Take 4-cyanoaniline, according to the appropriate molar ratio, and mix it with halogenated hydrocarbons in a suitable organic solvent, such as N, N-dimethylformamide (DMF). Add an appropriate amount of base, such as potassium carbonate, to promote the reaction. The temperature is controlled in a certain range, usually 50-80 ℃, and after stirring for several hours, the amino group of 4-cyanoaniline undergoes nucleophilic substitution reaction with halogenated hydrocarbons to obtain 4-cyanoaniline derivatives containing specific substituents.
Second step, synthesize 1-methyl-N- (pyridine-2-yl) -1H-benzo [d] imidazole-5-carboxylic acid. Using a suitable benzimidazole compound as the starting material, and methylating reagent, such as iodomethane, in an alkaline environment, such as sodium hydroxide solution, the methylation reaction is carried out to obtain 1-methyl benzimidazole intermediate. Thereafter, the intermediate reacts with pyridine-2-ylamine in a condensing agent such as 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC · HCl) and catalyst 4-dimethylaminopyridine (DMAP) in an organic solvent such as dichloromethane to form 1-methyl-N- (pyridine-2-yl) -1H-benzo [d] imidazole-5-carboxylic acid.
In the third step, the 4-cyanoaniline derivative obtained above is connected with 1-methyl-N- (pyridine-2-yl) -1H-benzo [d] imidazole-5-carboxylic acid. Under appropriate reaction conditions, such as in the presence of N, N-diisopropylethylamine (DIPEA), in acetonitrile solvent, the two condensation reactions occur to form a key connection structure.
The last step reacts with ethyl 3-halopropionate. The resulting product is reacted with ethyl 3-halopropionate in an anhydrous tetrahydrofuran solvent under the catalysis of a base, such as sodium hydride, at a low temperature, such as 0-5 ° C, to finally produce Ethyl 3- (2- ((4-cyanophenyl) amino methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate. After each step of the reaction, it needs to be separated and purified by extraction, column chromatography, etc., to obtain high-purity products in each step to ensure the quality and purity of the final product.
Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate
The market prospect of Ethyl+3-%282-%28%28%284 - cyanophenyl%29amino%29methyl%29 - 1 - methyl - N -% 28pyridin - 2 - yl% 29 - 1H - benzo%5Bd%5Dimidazole - 5 - carboxamido%29propanoate is related to many aspects.
This compound has a unique structure and may have great potential in the field of pharmaceutical research and development. Today's pharmaceutical market has a great demand for innovative drugs. If this compound can exhibit unique pharmacological activities, such as high-efficiency therapeutic effect for specific diseases, good safety and low toxic and side effects, it is expected to emerge in the market.
From the research and development process, if it is already in the stage of clinical trials, and the data is ideal, and it can be recognized by regulators, it will greatly enhance its market competitiveness. Pharmaceutical companies can take advantage of this advantage to quickly develop the market and obtain rich returns.
However, the market competition is also extremely fierce. Other similar or alternative compounds are also competing for share. If the research and development of this compound is lagging behind, or the production cost is too high, it is difficult to achieve large-scale production, or the curative effect is not significantly superior to competing products, the road to the market is full of thorns.
Furthermore, marketing activities and marketing strategies are also crucial. It is necessary to accurately target the target customer group, such as relevant specialized hospitals, doctors, etc. At the same time, use various academic conferences, medical exhibitions and other platforms to widely publicize its advantages and characteristics to enhance its visibility and reputation.
In summary, Ethyl+3-%282-%28%28%284 - cyanophenyl%29amino%29methyl%29 - 1 - methyl - N -% 28pyridin - 2 - yl% 29 - 1H - benzo%5Bd%5Dimidazole - 5 - carboxamido%29propanoate The market prospects, opportunities and challenges coexist. It is necessary for developers to move forward and grasp key factors in order to gain a place in the market.
Ethyl 3- (2- ((4-cyanophenyl) amino) methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5-carboxamido) propanoate What are the Quality Standards
Alas! This is an organic compound called "Ethyl 3- (2- ((4-cyanophenyl) amino methyl) -1-methyl-N- (pyridin-2-yl) -1H-benzo [d] imidazole-5 - carboxamido) propanoate". To know its Quality Standard, you need to look at it from multiple aspects.
First of all, the appearance should be pure and flawless, with uniform color and luster, and no foreign matter mixed in. Either white powder or crystalline state, it should show good uniformity. This is the first priority of the appearance Quality Standard.
Check the purity again, this is the key. Measured by high performance liquid chromatography, the purity should reach a very high level, generally exceeding 98% or even more than 99%. The content of impurities must be strictly controlled, and minor impurities may also affect their performance and use.
Melting point is also an important indicator. After accurate determination, there should be a specific melting point range with minimal deviation. This can help determine the integrity and purity of its material structure.
Moisture content cannot be ignored. Excessive water may damage the stability of the substance. Usually, the moisture level should be controlled at a low level, such as 0.5% or less, to ensure the stability of its chemical properties.
In terms of residual solvents, the residual amount of solvents used in the production process, such as ethanol, acetone, etc., should comply with relevant regulations and standards. For example, the residual amount of some organic solvents should be below the level of one part per million (ppm), so as not to affect the quality and safety of the product.
Heavy metal content, such as lead, mercury, cadmium, etc., needs to be strictly limited. Because of its high toxicity, even if it exists in a small amount, it may cause serious harm to subsequent use. Generally, it should be controlled at a very low level to ensure the safety of the product when used in various fields.
In summary, the Quality Standards of this compound are strictly controlled in terms of appearance, purity, melting point, moisture, residual solvent and heavy metal content to obtain high-quality products, which are suitable for many scientific research and industrial production needs.